Literature DB >> 29264865

Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines.

Salah Ghabri1, Irina Cleemput2, Jean-Michel Josselin3.   

Abstract

Mesh：

Year:  2018        PMID： 29264865     DOI： 10.1007/s40273-017-0603-4

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  19 in total

1.  Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease.

Authors:  K Claxton; P J Neumann; S Araki; M C Weinstein
Journal:  Int J Technol Assess Health Care       Date:  2001       Impact factor: 2.188

Review 2.  Confronting deep uncertainties in risk analysis.

Authors:  Louis Anthony Cox
Journal:  Risk Anal       Date:  2012-04-10       Impact factor: 4.000

3.  Applying health economics for policy decision making: do devices differ from drugs?

Authors:  Corinna Sorenson; Rosanna Tarricone; Markus Siebert; Michael Drummond
Journal:  Europace       Date:  2011-05       Impact factor: 5.214

4.  Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information.

Authors:  Malcolm J Price; Nicky J Welton; Andrew H Briggs; A E Ades
Journal:  Value Health       Date:  2011 Mar-Apr       Impact factor: 5.725

5.  A framework for addressing structural uncertainty in decision models.

Authors:  Christopher H Jackson; Laura Bojke; Simon G Thompson; Karl Claxton; Linda D Sharples
Journal:  Med Decis Making       Date:  2011-05-20       Impact factor: 2.583

6.  Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

Review 7.  HTA agencies facing model biases: the case of type 2 diabetes.

Authors:  Véronique Raimond; Jean-Michel Josselin; Lise Rochaix
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

Review 8.  Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward.

Authors:  Oriana Ciani; Marc Buyse; Michael Drummond; Guido Rasi; Everardo D Saad; Rod S Taylor
Journal:  Value Health       Date:  2016-12-22       Impact factor: 5.725

9.  Accounting for uncertainty in health economic decision models by using model averaging.

Authors:  Christopher H Jackson; Simon G Thompson; Linda D Sharples
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-04       Impact factor: 2.483

10.  AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.

Authors:  P Vemer; I Corro Ramos; G A K van Voorn; M J Al; T L Feenstra
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981
View more
  4 in total

Review 1.  Model Structuring for Economic Evaluations of New Health Technologies.

Authors:  Hossein Haji Ali Afzali; Laura Bojke; Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2018-11       Impact factor: 4.981

2.  How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea.

Authors:  SeungJin Bae; Joohee Lee; Eun-Young Bae
Journal:  Front Pharmacol       Date:  2022-05-16       Impact factor: 5.988

3.  A Dynamic Approach to Economic Priority Setting to Invest in Youth Mental Health and Guide Local Implementation: Economic Protocol for Eight System Dynamics Policy Models.

Authors:  Kenny D Lawson; Jo-An Occhipinti; Louise Freebairn; Adam Skinner; Yun Ju C Song; Grace Yeeun Lee; Sam Huntley; Ian B Hickie
Journal:  Front Psychiatry       Date:  2022-04-29       Impact factor: 5.435

4.  Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").

Authors:  Sabine E Grimm; Xavier Pouwels; Bram L T Ramaekers; Ben Wijnen; Saskia Knies; Janneke Grutters; Manuela A Joore
Journal:  Orphanet J Rare Dis       Date:  2021-02-01       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.